TrialBone marrow transplantation2017

Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.

L E Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.